General Information


DRACP ID  DRACP04069

Peptide Name  

Sequence  DILIIVGGGSGKERKKRRR

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H168N34O25

Absent amino acids  ACFHMNPQTWY

Common amino acids  GR

Mass  245979

Pl  12.1

Basic residues  7

Acidic residues  2

Hydrophobic residues  5

Net charge  5

Boman Index  -6778

Hydrophobicity  -92.63

Aliphatic Index  97.37

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32924418

Title  Targeted and Intracellular Antibacterial Activity against S agalactiae of the Chimeric Peptides Based on Pheromone and Cell-Penetrating Peptides

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16581

DRACP is developed by Dr.Zheng's team.